Stammdaten
Unternehmen
| Name | Alector, Inc. |
|---|---|
| Ticker | ALEC |
| CIK | 0001653087 |
Branche
| SIC-Code | 2836 |
|---|---|
| Beschreibung | Biological Products, (No Diagnostic Substances) |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | Alector, Inc. |
Status
| Zuletzt geprüft | 2026-03-20 22:37:58.514334 |
|---|
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-03 | Wong-Sarad Grace | Officer, Principal Accounting Officer | Open Market Sale | -3,367 | 2.08 | -7,012.11 | -13,1% | |
| 2026-03-02 | Wong-Sarad Grace | Officer, Principal Accounting Officer | Open Market Sale | -8,071 | 2.12 | -17,137.96 | -32,1% | |
| 2026-03-02 | Rosenthal Arnon | Director, Officer, Chief Executive Officer | Open Market Sale | -81,864 | 2.12 | -173,821.83 | -325,3% | |
| 2026-03-02 | Berkley Neil Lindsay | Officer, CFO & Chief Business Officer | Open Market Sale | -29,649 | 2.12 | -62,953.72 | -117,8% | |
| 2025-12-05 | Wong-Sarad Grace | Officer, Principal Accounting Officer | Open Market Sale | -4,753 | 1.21 | -5,751.13 | -10,8% | |
| 2025-12-03 | Wong-Sarad Grace | Officer, Principal Accounting Officer | Open Market Sale | -8,056 | 1.12 | -9,018.69 | -16,9% | |
| 2025-12-03 | Rosenthal Arnon | Director, Officer, Chief Executive Officer | Open Market Sale | -104,347 | 1.12 | -116,826.90 | -218,6% | |
| 2025-12-03 | Kenkare-Mitra Sara | Officer, President and Head of R&D | Open Market Sale | -41,687 | 1.12 | -46,672.77 | -87,3% | |
| 2025-12-03 | Berkley Neil Lindsay | Officer, Chief Bus Ofcr & Interim CFO | Open Market Sale | -37,261 | 1.12 | -41,717.42 | -78,1% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.